PCM
PRCT icon

Peregrine Capital Management’s Procept Biorobotics PRCT Stock Holding History

Peregrine Capital Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.67M Buy
+251,296
New +$6.29M 0.18% 167
2026
Q1 		– Sell
-185,824
Closed -$5.85M – 315
2025
Q4 		$5.85M Sell
185,824
-2,395
-1% -$79.4K 0.18% 161
2025
Q3 		$6.72M Buy
+188,219
New +$8.59M 0.2% 139

Other funds holding PRCT

KCM
KRS Capital Management Bloomfield, Michigan $215M AUM 69.3% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
EA
Enclave Advisors Austin, Texas $790M AUM 21.99% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Peregrine Capital Management's PRCT Position: Q2 2026 in Review

Peregrine Capital Management opened a new position in Procept Biorobotics (PRCT) in Q2 2026: 251,296 shares worth $5.67M. The stake represents 0.18% of the portfolio and ranks #167 among its holdings. This is a return to the name: Peregrine Capital Management previously reported a position in PRCT as recently as Q4 2025.

Peregrine Capital Management first reported a position in PRCT in Q3 2025 and has held it in 3 quarters since. The position peaked at $6.72M in Q3 2025. 20 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Peregrine Capital Management held 251,296 shares of Procept Biorobotics worth $5.67M as of Q2 2026.
  • Procept Biorobotics was a new Peregrine Capital Management position in Q2 2026.
  • Procept Biorobotics made up 0.18% of Peregrine Capital Management's portfolio in Q2 2026, its #167 holding.
  • Peregrine Capital Management first reported a position in Procept Biorobotics in Q3 2025 and has held it in 3 quarters since.
  • Peregrine Capital Management's Procept Biorobotics position peaked at $6.72M in Q3 2025.
  • 20 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Peregrine Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.